Prologue Journal

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion

• prologu5
• 04/10/202404/10/2024

Wall Street Journal

Transaction would give the pharmaceutical giant access to Alpine’s potential treatment for chronic kidney disease.

https://www.wsj.com/articles/vertex-pharmaceuticals-to-acquire-alpine-immune-sciences-for-4-9-billion-7edbeaeb